Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Centre Hospitalier Universitaire de Nice.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice
First received: March 12, 2010
Last updated: December 7, 2011
Last verified: March 2010
During the last years, the investigators were the witness to the increase of a old emerging pest due to bed bugs (Cimex lectularius) in the world. Insecticides resistances apparitions and internationals transports increases seem to be the reasons of the pest. Cimex lectularius as vector of parasites, bacteria or virus was often suggested although not much observation are recently investigated in France. This study intends to examine the vectorial ability and the direct pathogenicity of Cimex lectularius.
Other: Collection of the bedbugs and dermatological follow-up of the stings
||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
||Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role
Primary Outcome Measures:
- Morphological identification of every bedbug Porterage of bacterial agents Porterage of viral agents Biomolecular identification of the insect A breeding of bedbugs Tests of sensibility in insecticides [ Time Frame: day 1 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Study of the direct pathogenicity of lectularius C. [ Time Frame: day 1, 7, 15 and 30 ] [ Designated as safety issue: No ]
During each of four consultations a questionnaire and a descriptive index card(form) of the general and dermatological signs will be informed. The criteria of evaluation, associated with anonimisées photos, are split into two groups: general Signs and dermatological Signs
| Estimated Enrollment:
| Study Start Date:
| Estimated Primary Completion Date:
||March 2012 (Final data collection date for primary outcome measure)
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- On the site of takings presence of insects and eggs evoking bedbugs of beds. The identification of certainty will be made in the laboratory. All the insects not apartment to the family of Cimicidae (Criterion of exclusion) are thrown(cast) in trash cans of laboratories for organic products.
- voluntary Patients after reading of the information sheet and the signature of the consent
- Membership of the patient in the national insurance scheme
- On the site of takings absence of insects and eggs evoking bedbugs of beds
- During the identification of certainty in the laboratory, the captured insects do not make parties of the family of Cimicidae
- The subjects deprived of freedom.
- Patients cancelling their consent.
- Patients violating the protocol of search(research)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01089465
|Collection of the bedbugs and dermatological follow-up of the stings
|Nice, France, 06000 |
|Contact: Pascal Delaunay, PH 04.92.03.62.54 email@example.com |
|Principal Investigator: Pascal Dr Delaunay, PH |
Centre Hospitalier Universitaire de Nice
||Pascal Delaunay, Dr
||CHU de Nice
No publications provided
||Centre Hospitalier Universitaire de Nice
History of Changes
|Other Study ID Numbers:
|Study First Received:
||March 12, 2010
||December 7, 2011
||France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Keywords provided by Centre Hospitalier Universitaire de Nice:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 20, 2014
Bites and Stings
Wounds and Injuries